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ABSTRACT
Objective: Investigate differences in the infectious aetiology, health seeking behaviour, 
and provider practices with regard to diarrhoeal illness among children presenting to 
urban versus rural clinics in Western Kenya.
Design: Laboratory-based, passive surveillance.
Setting: The urban portion of the study was conducted at the paediatric outpatient 
clinic of Nyanza Provincial Hospital in Kisumu. The rural portion of the study was 
conducted at four outpatient clinics in the Asembo Bay community approximately 20 
kilometers west of Kisumu. 
Subjects: Children aged less than five years presenting to medical facilities for the 
treatment of diarrhoea from October 2001-October 2003 at the urban site and May 
1997-April 2003 for the rural sites. 
Results: Among the 1303 urban and 1247 rural specimens collected, 24% of specimens 
yielded a bacterial pathogen (24% urban, 25% rural). Campylobacter was the predominant 
bacterial pathogen (17% urban, 15% rural), followed by Shigella and nontyphoidal 
Salmonella (both 4% urban and 5% rural). In both communities, susceptibilities of these 
pathogens to the most commonly prescribed antibiotics was low (<50%); 70% of all 
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INTRODUCTION
Diarrhoeal disease remains a major cause of morbidity 
and mortality in developing countries (1). Few 
systematic analyses have been published comparing 
aetiologic agents of diarrhoea and associated health 
practices in urban and rural communities in sub-
Saharan Africa (2). Research is warranted to describe 
and understand differences between urban and 
rural communities within the same region given the 
potential differences in exposures and in the extent 
of training and experience of health care providers in 
each community. We compared paediatric diarrhoeal 
disease surveillance data collected from urban and 
rural sites in western Kenya to explore differences in 
bacterial aetiologies, antimicrobial resistance patterns, 
and health care practices. 
MATERIALS AND METHODS
Study site: The study was conducted in Kenya’s 
Nyanza Province, which borders Lake Victoria in 
western Kenya. The urban portion of the study 
was conducted at the paediatric outpatient clinic 
of Nyanza Provincial Hospital in Kisumu, Kenya’s 
third largest city (population 322,724) (3); the 
hospital is a public government facility that serves 
primarily residents of Kisumu. The rural portion of 
the study was conducted at four outpatient clinics 
(two government-supported located in the villages of 
Ongielo and Abidha, two privately supported located 
in Lwak and Rarieda, later Sarididi) in the Asembo 
Bay community, approximately 20 kilometers west 
of Kisumu. Of the privately supported clinics, one 
was the clinic associated with a mission hospital 
while the other was a private solo provider. Asembo 
Bay is an area composed of 79 villages organised as 
loose conglomerates of family compounds separated 
by garden plots, grazing land and streams. Fishing, 
raising cattle, and subsistence farming are the 
principal occupations. In 1996, the population was 
55,000 spread out over an area of an area of 200 km2 
(2,4,5).
Surveillance and specimen collection: We conducted 
clinic-based diarrhoeal surveillance with laboratory 
diagnosis at the urban clinic from October 18, 2001 
through October 17,2003. Each weekday, the first five 
children aged <5 years who presented to the clinic 
with a chief complaint of diarrhoeal illness were 
enrolled following informed consent. Because of the 
high patient volume at the urban site, only two years 
were required to obtain a sample size comparable to 
the rural sites. However, we conducted surveillance 
using the same methods at the rural clinics from May 
1,1997 through April 30, 2003. During this period, 
every eligible resident of the study area presenting 
with the chief complaint of diarrhoeal illness at the 
rural clinics was offered an opportunity to enroll in 
the study. Data from the rural surveillance study 
have been previously reported (5, 6); we report here 
observations and analyses of data for children aged 
<5 years not previously presented. 
 We defined diarrhoea as >3 bowel movements 
in any 24-hour period within the preceding five days. 
We characterised diarrhoea as bloody if blood was 
visible in the specimen or the caretaker reported seeing 
blood in the patient’s stool. Non-bloody diarrhoea was 
categorised as watery or mucoid, or if not described, 
uncharacterised. 
 For each enrolled child, we collected 
demographic information and medical histories 
including symptoms, medications taken before 
the visit, medications prescribed at the visit, and 
a stool specimen (either whole stool or a Dacron® 
rectal swab). Rectal swabs and swabs of whole 
stool specimens were placed in Cary-Blair transport 
medium, refrigerated at 4-8°C, and transported 
within 48 hours of collection to the KEMRI/CDC 
Microbiology Laboratory. 
Laboratory procedures: All stool specimens were 
cultured for Shigella, Salmonella, Vibrio and 
Campylobacter species. Pathogens were isolated, 
identified, and serotyped by standard methods. 
We determined antimicrobial susceptibilities of 
Shigella, Salmonella and Vibrio cholerae isolates to 
ampicillin, amoxicillin-clavulanate, ceftriaxone, 
chloramphenicol, ciprofloxacin, gentamicin, 
kanamicin,  nal idixic  acid,  streptomycin, 
sulfisoxazole, tetracycline, and trimethoprim-
sulfamethoxazole (TMP/SMX) by the Kirby-Bauer 
disk diffusion method (7). We tested a randomly 
selected subset of Campylobacter isolates using the 
E-Test® method (AB Biodisk, Piscataway, NJ) for 
susceptibility to chloramphenicol, ciprofloxacin, 
clindamycin, erythromycin, cephalothin, nalidixic 
acid, tetracycline, and TMP/SMX (8). Serotypes 
episodes of diarrhoea were prescribed antibiotic treatment. Urban health practitioners 
prescribed fewer antibiotics, chose drugs more likely to be effective, and were more 
likely to prescribe oral rehydration therapy for bloody diarrhoea. 
Conclusion: Most characteristics of diarrhoeal disease and their causes were similar in 
paediatric patients presenting to urban and rural clinics. Urban providers were more 
compliant with WHO recommendations. 
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of S. dysenteriae, S.flexneri, and all Salmonella were 
determined by standard methods using commercial 
antisera (9).
Statistical methods: We conducted statistical analyses 
using STATA version 7.0 (STATA Corporation, College 
Station, TX). We calculated Pearson’s chi-square, 
odds ratios (OR), and their exact 95% confidence 
intervals (95% CI). We report the mean of continuous 
data and tested for normality. Finding the data not 
normal, we report interquartile ranges and compared 
the distributions using the Mann-Whitney test. We 
applied linear regression analysis to examine linear 
relationships between pathogen isolation rates and 
patient age; we report the slope of the regression line 
(β), its 95% CI, and the P-value for the association. 
Age-specific isolation rates were calculated using 
6-month age categories (0-5 months, 6-11 months, 
12-17 months). Noting that Campylobacter isolation 
rates peaked among 6-12 month old children, we 
further examined Campylobacter isolation rates 
for the children aged <12 months by one-month 
age categories. We used logistic regression for all 
comparisons between urban and rural communities 
in order to control for differences in age distribution. 
We also controlled for the significantly greater number 
of unserotyped Salmonella from the urban site using 
logistic regression. To compare treatment patterns 
for dysentery (diarrhoeal stool containing blood), 
we developed a regression model that included 
prescription of any of the following for patients with 
bloody diarrhoea: oral rehydration solution (ORS), 
intravenous (IV) fluid, and antibiotics with Gram-
negative rod (GNR) activity. When the analysis was 
restricted to only the data collected during the 18 
month period of overlap in which the study was 
conducted at both the urban and rural sites, similar 
results were obtained but the smaller sample size and 
consequent loss of power led to a loss of statistical 
significance for several specific comparisons. We 
therefore included all data from both communities 
in our analyses. 
Scientific ethics: The KEMRI Ethical Review Committee 
and the CDC Institutional Review Board approved the 
protocol for the present research. Parents or guardians 
of all subjects provided informed consent. 
RESULTS
Specimen and population characteristics: A total of 1303 
urban patients and 1247 rural patients were enrolled 
during the respective periods of surveillance. The 
mean age of urban enrollees was 12 months compared 
with 16 months among rural enrollees (P<0.001, 
Table 1). In addition, the proportional distribution 
of age group membership was skewed for both 
communities, with less than 5% of children being 
older than 48 months (Figure 1). Urban patients 
presented to study clinics for evaluation on average 
one day earlier after onset of symptoms than rural 
patients (mean 3.6 days vs. 4.4 days, IQR 2-4 days vs. 
2-5 days, P <0.001). Although the frequency of nausea 
(61% urban vs. 64% rural) and vomiting (60% vs. 62%, 
respectively) accompanying the diarrhoeal illness 
were not significantly different between communities, 
urban patients reported significantly less subjective 
fever (73% vs. 82%, OR  0.59, 95% CI  0.48-0.71, P<0.001) 
and abdominal cramping (63%vs. 75%, OR 0.53,95% 
CI 0.45-0.64, P <0.001).  A significantly greater fraction 
of urban patients presented with watery diarrhoea 
(95% vs. 71%, OR 6.42, 95% CI 4.59-8.98, P<0.001) 
whereas urban children were less likely to present 
with bloody(3%vs. 10%, OR 0.35, 95% CI 0.25-0.51, 
P<0.001) ormucoid (1% vs. 14%, OR 0.28, 95% CI 
0.22-0.37, P <0.001) diarrhoea. 
Figure 1
Age distribution of patients presenting with diarrhoea 
to urban and rural clinics, Western Kenya, May 1997-
October 2003
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Table 1
Comparison of demographics, clinical characteristics, and bacterial enteric pathogens isolated from urban and rural 
paediatric outpatients with diarrhoea: Western Kenya, May 1997-October 2003a
 Urban (n=1303) Rural (n=1247)  OR (95% CI)b  P-value 
Demographics     
  Mean age, months  12 (5-16)  16 (7-22)  --  <0.001 
  Interquartile range [IQR]     
  Female  592/1,300 (46%)  588/1,245 (47%)  1.05 (0.89-1.23)  0.56 
Clinical data     
  Mean days from onset  3.6 (2-4)  4.4 (2-5)  --  <0.001 
  to clinic visit (IQR)     
  Subjective fever  950/1,300 (73%)  1020/1,244 (82%)  0.59 (0.48-0.71)  <0.001 
  Abdominal cramping  811/1,296 (63%)  886/1,184 (75%)  0.53 (0.45-0.64)  <0.001 
  Nausea  799/1,300 (61%)  764/1,191 (64%)  0.87 (0.73-1.02)  0.089 
  Vomiting  784/1,300 (60%)  775/1,245 (62%)  0.88 (0.74-1.04)  0.13 
Quality of diarrhoea     
  Wateryc  1,240 (95%)  904 (71%)  6.42 (4.59-8.98)  <0.001 
  Bloodyd  45 (3%)  124 (10%)  0.35 (0.25-0.51)  <0.001 
  Mucoide  7 (1%)  182 (14%)  0.28 (0.22-0.37)  <0.001 
  Uncharacterisedf  11 (1%)  55 (4%)  0.20 (0.10-0.38)  <0.001 
Stool culture results     
  No growth  3 (<1%)  8 (1%)  0.41 (0.11-1.62)  0.21 
  Normal growth  991 (76%)  937 (75%)  1.05 (0.88-1.27)  0.58 
  Yielded a pathogen  309 (24%)  302 (25%)  0.97 (0.80-1.16)  0.72 
  Yielded > 1pathogen  16 (1%)  19 (2%)  0.85 (0.43-1.69)  0.65 
  Total pathogens isolated  325  321   
Pathogen isolation ratesg     
  Bloodyc  14/45 (31%)  47/124 (38%)  1.01 (0.84-1.22)  0.93 
  Wateryd  290/1,240 (23%)  198/886 (24%)  1.05 (0.87-1.28)  0.60 
  Mucoide  2/7 (29%)  47/182 (26%)  0.98 (0.81-1.19)  0.85 
  Uncharacterisedf  3/11 (27%)  10/55 (18%)  0.96 (0.80-1.16)  0.69 
Species isolated     
  Campylobacter  224/1,303 (17%)  193/1,247 (15%)  1.04 (0.82-1.29)  0.70 
  All Shigella species  51/1,303 (4%)  65/1,247 (5%)  0.98 (0.66-1.44)  0.90 
  S. flexneri  33/51 (65%)  38/65 (58%)  1.34 (0.62-2.91)  0.46 
  S. sonnei  7/51 (14%)  16/65 (25%)  0.48 (0.19-1.19)  0.11 
  S. boydii  4/51 (8%)  5/65 (8%)  0.95 (0.23-3.87)  0.95 
  S. dysenteriae, non-type 1  3/51 (6%)  3/65 (5%)  1.65 (0.29-9.33)  0.57 
  S. dysenteriae, type 1  0/51 (0%)  3/65 (5%)  NAh  NA 
  S.spp. unserotyped  4/51 (8%)  0/65 (0%)  NA  NA 
  Nontyphoidal Salmonella  49/1,303 (4%)  61/1,247 (5%)  0.72 (0.48-1.06)  0.10 
  Group B Salmonella  31/49 (43%)  24/61 (39%)  2.91 (1.32-6.46)  0.008 
  Group C1 Salmonella  2/49 (4%)  2/61 (3%)  1.56 (0.21-11.6)  0.67 
  Group C2 Salmonella  3/49 (6%)  5/61 (8%)  0.69 (0.16-3.01)  0.63 
  Group D Salmonella  10/49 (20%)  19/61 (31%)  0.57 (0.23-1.37)  0.21 
  Group E Salmonella  0/49 (0%)  5/61 (8%)  NA  NA 
  Group F Salmonella  0/49 (0%)  3/61 (5%)  NA  NA 
  Salmonella, otheri  1/49 (2%)  2/61 (3%)  NA  NA 
  Salmonella spp., not grouped  2/49 (4%)  1/61 (2%)  2.1 (0.19-25.47)  0.53 
  Salmonella enterica serotype Typhi  1/1,303 (1%)  0/1,247 (0%)  NA  NA 
  Vibrio cholerae O1  0/1,303 (0%)  1/1,247 (<1%)  NA  NA 
  Other vibrio spp.  0/1,303 ( 0%)  1/1,247 <1%)  NA  NA 
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Bacterial isolates: Bacterial isolation rates were 
comparable between the urban and rural communities: 
24% vs. 25% of specimens, respectively, yielded 
at least one bacterial pathogen and 1% vs. 2% of 
specimens yielded >1 pathogen (Table 1). There 
were no significant differences in isolation rates 
according to type of diarrhoea for each community: 
31% vs. 38% for bloody diarrhoea, 29% vs. 26% 
for watery diarrhoea, and 23% vs. 24% for mucoid 
diarrhoea. Campylobacter was the most common 
bacterial pathogen identified; isolated from 17% 
(urban) vs. 15% (rural) of all specimens. Whether 
considered together or individually, there was no 
significant difference in the rates of isolation of 
Shigella serogroups from the specimens of patients 
from urban compared to rural communities (4% vs. 
5% of all specimens). Among the Shigella isolates, the 
proportion of each species in urban vs. rural sites 
was 65% vs. 58% for S.flexneri, 14% vs. 25% for S. 
sonnei, 8% vs. 8% for S. boydii, 6% vs. 5% for non-type 
1 S. dysenteriae, 0% vs. 5% for type 1 S. dysenteriae; 
8% vs. 0% were not serogrouped(Table 1). S.flexneri 
serotypes included 2a(21% vs. 24%), 1b (15% vs. 24%), 
3a(15% vs. 13%), 4a (9% vs. 0%) and 6 (6% vs. 18%) 
(Table 2). However, the sub-analysis of serogroups 
and serotypes of Salmonella species revealed that 
Group B Salmonella and Salmonella enterica serotype 
Typhimurium, which belongs to Group B, were more 
common in urban patients (43% vs. 39%, OR 2.91, 
95% CI 1.32-6.46, P0.008 and 31% vs. 18%, OR 3.40, 
95%CI 1.29-8.96, P=0.014, respectively). The other 
most common nontyphoidal Salmonella isolated were 
Salmonella enterica serotype Enteritidis (21% vs. 18%), 
Salmonella enterica serotype Newport (6% vs. 2%), 
and Salmonella enterica serotype Heidelberg (10% vs. 
16%) (Table 2). One specimen from an urban patient 
yielded Salmonella enterica serotype Typhi. 
a. Surveillance data for Kisumu (urban) is limited to October 200l-october 2003. Asembo Bay(rural) is limited to May 
1997-June 2003 and is a subset of a previously published data consisting of only patients 0-5 years old.6 
b. Adjusted by age. 
c. Reported “watery diarrhoea” but denied “bloody diarrhoea”, excluded unknown responses for “bloody diarrhoea” 
d. Reported “bloody diarrhoea” but may also have reported “watery” and/or “mucoid diarrhoea.” 
e. Reported “mucoid diarrhoea” alone. denied both “bloody” and “watery diarrhoea”, excluded unknowns responses 
for “bloody diarrhoea” and for “watery diarrhoea.’ 
f. Reported “uncharacterised” all responses regarding stool quality were blank 
g. For this table pathogens include: Shigella Salmonella, Vibrio, and Campylobacter. 
h. NA Not Applicable: Zero value or collinearity prevents calculating adjusted OR and P-value; 
i. In Kisumu there was one isolate of Salmonella II 1, 13, 23:29 that could not be serogrouped; in Asembo Bay there 
was one each of, Salmonella enterica serotype Leoben (Group M), Salmonella enterica serotype Taiping (Group G)
 
Table 2
Shigella and nontyphoidal Salmonella serotypes from children with diarrhoea: Western Kenya, May 1997-October 
2003a
 Urban Rural OR (95% CI)b P-value
S. flexneri serotypes    
  2a 7/33 (21%) 9/38 (24%) 0.78 (0.29-2.13) 0.63
  1b 5/33 (15%) 9/38 (24%) 0.76 (0.23-2.51) 0.66
  3a 5/33 (15%) 5/38 (13%) 1.31 (0.35-4.92) 0.69
  4a 3/33 (9%) 0/38 (0%) NAc NA
  6 2/33 (6%) 7/38 (18%) 0.28 (0.05-1.46) 0.13
  Otherd 1/33 (3%) 3/38 (8%) 0.39 (0.04-4.03) 0.43
  Unserotyped 10/33 (30%) 5/38 (13%) 3.3 (0.94-11.7) 0.063
Nontyphoidal Salmonella serotypes    
  Salmonella enterica serotype Typhimurium (Group B) 15/49 (31%) 11/61 (18%) 3.40 (1.29-8.96)d 0.014
  Salmonella enterica serotype Enteritidis (Group D) 7/49 (21%) 18/61 (30%) 0.62 (0.22-1.71)d 0.35
  Salmonella enterica serotype Heidelberg (Group B) 5/49 (10%) 10/61 (16%) 0.96 (0.29-3.23)d 0.95
  Salmonella enterica serotype Newport (Group C2) 3/49 (6%) 1/61 (2%) 5.05 (0.50-51.0)d 0.17
  Salmonella enterica serotype Kenya (Group C1) 2/49 (4%) 0/61 (0%) NA NA
  Salmonella enterica serotype 4,S,12:A:-Monophasic 2/49 (4%) 0/61 (0%) NA NA
  (Group B)    
  Salmonella enterica serotype Aberdeen (Group F) 0/49 (0%) 3/61 (5%) NA NA
  Salmonella enterica serotype Uganda (Group E) 0/49 (0%) 3/61 (5%) NA NA
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  Salmonella enterica serotype Chailey (Group C2) 0/49 (0%) 2/61 (3%) NA NA
  Othere 1/49 (2%) 9/61 (15%) NA NA
  Unserotyped 14/49 (29%) 4/61 (7%) 5.87 (1.76-19.6) 0.004
a.  Surveillance data for Kisumu (urban) is limited to October 2001-october 2003. Asembo Bay (rural) is limited to 
May 1997-June 2003 and is a subset of a previously published data consisting of only patients 0-5 years old (6). 
b. Adjusted by age.
c. NA= Not Applicable: Zero value prevents or collinearity prevents calculating adjusted OR and P-value.
d. In Kisumu there was one isolate each Shigella flexneri serotype X variant. In Asembo Bay there was one isolate 
each of Shigella flexneri serotype 1 A, Shigella flexneri serotype 3B, and Shigella flexneri serotype 4B.
e.  Adjusted by age and unserotyped Salmonella 
f.  In Kisumu there was one isolate of Salmonella II 1, 13, 23:229. In Asembo Bay there was one isolate each of 
Salmonella enterica serotype Bardo (Group C2), Salmonella enterica serotype 1turi (Group B), Salmonella enterica 
serotype Leoben (Group M), Salmonella enterica serotype Lindenburg (Group Cl), Salmonella enterica serotype 1 6, 
7,[I4]:b:- (Group C1), Salmonella enterica serotype Taiping (Group G), Salmonella enterica serotype Zanzibar (Group 
EI), and one nontypable (Group C2) and one nontypable (not serogrouped).
Table 3
Antimicrobials taken by paediatric outpatients with diarrhoea before seeking medical attention, Western Kenya, 
May 1997-October 2003a
  Self-prescribed before seeking medical attention   Prescribed by health care provider  
 Urban  Rural  OR (95% CI)b P-value Urban  Rural  OR (95% CI)b  P-value
          
Any antimicrobial  189 (15%)  284 (23%)  0.58 (0.46-0.70)  <0.001  875 (67%)  920 (73%)  0.73 (0.61-0.87)  <0.001 
Any antimicrobial 
active against  116 (9%)  168(13%)  0.61 (0.47-0.79)  <0.001  852 (65%)  475 (38%)  2.91 (2.47-3.44)  <0.001 
Gram-negative rods (GNR)         
Specific antibiotics         
with GNR activity       
 Amoxicillin or Ampicillin  26 (2%)  21 (2%)  1.39 (0.74-2.60)  0.30  22 (2%)  186 (15%)  0.09 (0.06-0.15)  <0.001 
 Amoxicillin-clavulanate  0 (0%)  0  (0%)  NAc NA  3 (<1%)  0 (0%)  NA  NA
 Cephalosporin  1 (< 1%)d  0  (0%)  NA NA  32 (2%)e  0 (0%)  NA  NA 
 Chloramphenicol  0(0%)  1 (<1%)  NA  NA 3 (<1%)  25 (2%)  0.10 (0.03-0.35)  <0.001 
 Doxycycline  1 (<1%)  3 (<1%)  0.49 (0.5-5.17)  0.55  0(0%)  4 (<1%)  NA  NA 
 Erythromycin  3 (<1%)  9 (1%)  0.32 (0.08-1.21)  0.09  292 (22%)  38 (3%)  8.92 (6.28-12.70)  <0.001 
 Gentamicin  0  (0%)  2 (<1%)  NA  NA  1 (<1%)  36 (3%)  0.02 (0.00-0.17)  <0.001 
 Nalidixic acid  0  (0%)  1 (<1%)  NA NA  23 (2%)  37 (3%)  0.59 (0.04-0.13)  <0.001 
 Sulfadoxine-
 pyrimethamine§  21 (2%)  55 (4%)  0.35 (0.21-0.59)  <0.001  451 (35%)  279 (22%)  1.87 (1.56-2.24)  <0.001 
 Tetracycline  7 ( 1%)  21 (2%)  0.43 (0.34-0.62)  <0.001  1 (<1%)  6 (<1%)  0.13 (0.02-1.13)  0.064 
 Trimethoprim-
 sulfamethoxazole   78 (6%)  144 (12%)  0.46 (0.34-0.62)  <0.001  296 (23%)  358 (28%)  0.70 (0.59-0.85)  <0.001
Specific antibiotics      
without GNR activity       
 Cloxacillin  0 (0%)  0 (0%)  NA  NA   0(0%)  2 (<1%)  NA  NA
 Metronidazole  72 (6%)  100 (8%)  0.69 (0.50-0.95)  0.02  11(1%)  316 (25%)  0.02 (0.01-0.05)  <0.001
 Penicillin  1 (<1%)  18 (1%)  0.51 (0.01-0.39)  0.004  12 (1%)  136 (11%)  0.07 (0.04-0.13)  <0.001
 
a. Surveillance data for Kisumu (urban) is limited to October 2001 - October 2003. Asembo Bay (rural) is limited to 
May 1997-June 2003 and is a subset of a previously published data consisting of only patients 0-5 years old; (6)
b. Adjusted by age; d Cephalexin (1); e  Includes cephalexin (6), cefadroxil (12), cefazolin (3), cefaclor (10), and 
cefufur (I); ‘11 Sulfonamide-containing anti malarial.
c. NA = Not applicable: Zero value prevents or collinearity prevents calculating adjusted OR and P-value
d. Cephalexin (1)
e. Includes cephalexin (6)
f. Sulfonamide - Containing
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 Although age-specific isolation rates varied 
significantly by pathogen, patterns of isolation were 
similar in urban and rural populations (Figure 2). For 
instance, an analysis of Campylobacter isolation rates 
among infants using one month intervals indicated 
that the peak isolation rate of 31 per 100 diarrhoea 
cases occurred among urban infants who were 12 
months old, while a peak isolation rate of 29 per 100 
diarrhoea cases occurred among rural children who 
were 10 months old. Shigella isolation rates tended 
to increase with increasing age in urban and rural 
patients (β 0.04, 95% CI 0.02-0.05, P <0.001; β 0.03, 
95% CI 0.01-0.04, P <0.001). The age-specific isolation 
rates for nontyphoidal Salmonella remained stable 
across age categories (β−0.002, 95% CI -0.01-0.02, P 
0.74; β -0.006, 95% CI -0.02-0.005, P 0.24). 
Associations with presenting signs and symptoms: 
Shigela was significantly more likely to be isolated 
from bloody specimens in both communities (OR 
7.17,95% CI 2.84-16.39, P<0.001 vs. OR 7.35,95% CI 
4.10-12.96, P<0.001). Isolation of Campylobacter or 
nontyphoidal Salmonella was not associated with any 
type of diarrhoea eg watery, blody, etc. There was no 
other association among isolates with other presenting 
symptoms (such as, fever, abdominal cramps, nausea, 
vomiting) by community. 
Diarrhoeal treatment, antimicrobial use and susceptibility 
testing: Before presenting to the clinic, urban enrollees 
were less likely to have taken antimicrobials (15% vs. 
21%, OR 0.58,95% CI 0.46-0.70, P <0.001) or herbal 
remedies (3% vs. 16%, OR 0.17, 95% CI 0.12-0.23, 
P<0.001). Use of ORS before the visit was equally 
low in both settings (4% vs. 4%). 
 The World Health Organisation recommends 
antimicrobial therapy only for treatment for 
dysentery and for moderate to severe cholera with 
an antibiotic active against GNR in additional to 
standard hydration therapy (10). Antibiotics active 
against GNR include TMP/SMX, aminopenicillins, 
third-generation cephalosporins, nalidixic acid, 
and fluoroquinolones. Patients were less likely to 
be prescribed any antimicrobial agent in the urban 
community (67% vs. 73%, OR 0.73,95% CI 0.61- 0.87, P 
<0.001) and were also less likely to be prescribed more 
than one agent (21% vs. 33%, OR 0.68, 95% CI 0.62-
0.75, P<0.001). Antimicrobials prescribed at the urban 
clinic were more likely to have activity against GNR 
(65% vs. 38%, OR 2.91, 95% CI 2.47-3.44, P <0.001). 
In terms of specific antimicrobial agents, providers 
at the urban clinic were significantly more likely to 
prescribe erythromycin (22% vs. 3%, OR 8.92, 95% 
CI 6.28-12.70, P<0.001) and significantly less likely to 
prescribe aminopenicillins (2% vs. 15%, OR 0.09,95% 
CI 0.06-0.15, P<0.001) or metronidazole (1% vs. 25%, 
OR 0.02, 95% CI 0.01-0.05, P <0.001). Our regression 
model examining the differences in treatment of 
dysentery revealed that despite the fact that bloody 
diarrhoea was less common in urban patients, children 
presenting with bloody diarrhoea to the urban clinic 
were more likely to have been prescribed ORS (OR 
11.63, 95% CI 1.07-126.3, P 0.04) and an antibiotic with 
GNR activity (OR 4.24,95% CI 1.99-9.04, P <0.001). 
 Antimicrobial susceptibility patterns were also 
similar for isolates from urban and rural patients 
(Table 4). Susceptibilities of Shigella and nontyphoidal 
Salmonella to TMP-SMZ were low (17% urban vs. 25% 
rural) (Table 4). The only antimicrobials to which 
more than 80% of Salmonella and Shigella isolates were 
susceptible were ciprofloxacin, ceftriaxone, nalidixic 
acid, kanamyicin, and gentamicin. Susceptibilities 
of Campylobacter to the antibiotics tested were 
>80% in both communities except for clindamycin, 
erythromycin, TMP-SMZ and nalidixic acid (Table 
4). Only 33% to 45% of isolates were susceptible 
to erythromycin, but more than half of isolates 
demonstrated intermediate susceptibility. Overall, 
providers at the urban clinic were significantly less 
likely to prescribe antibiotics to which the patient’s 
isolate was resistant (19% vs. 81 %, OR 0.22, 95% CI 
0.12-0.45, P <0.001). 
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Figure 2
Comparison of age-specific isolation rates for Campylobacter, Shigella, and Salmonella from patients ages 0-5 years 




August 2009 EAST AFRICAN MEDICAL JOURNAL   395
Table 4
Antimicrobial susceptibility patterns among selected Shigella serogroups and Salmonella serotypes isolated from 
children with diarrhoea: Western Kenya, May 1997-October 2003.a
 
       Percent susceptible isolatesb 
Pathogen (Number)  CH TS TE  CP  NA  A  SZ  S  K  G  CT  A-C  CL  E  CES
Urban            
  Shigella & non-typhoidal                
  Salmonella (n=99) T 57  17  19  100  93  31  7  16  84  84  100  38  -  -  - 
  Shigella (n=51)  44  2  9  100  98  27  6  8  100  98  100  37  -  -  - 
  S. flexneri (n=33)  24  3  3  100  100  18  9  9  100  97  100  27  -  -  - 
  S. sonnei (n=7)  100  0  0  100  100  86  0  0  100  100  100  100  -  -  - 
  Nontyphoidal Salmonella (n=48)  72  33  31  100  87  35  8  25  42  69  100  40  -  - -
  S. ser. Typhimurium (n=15)  93  20  33  100  100  7  0  13  27  27  100  20  -  -  - 
  S. ser. Enteritidis (n=7) 40  40  0  100  40  29  14  29  86  100  100  29  -  -  - 
  Campylobacter (n=24)  92  88  92  92  92  -  -  -  -  -  -  -  79  33  9 2 
Rural               
  Shigella & nontyphoidal  52  25  21  100  94  44  12  16  93  93  100  48  - -  - 
  Salmonella (n=122)               -  
  Shigella (n=65)  43  3  3  100  97  35  3  2  100  100  100  42  -  -  - 
  S. flexneri (n=38)  6  6  0  100  94  13  5  3  100  100  100  21  -  -  - 
  S. sonnei (n=16)  100  0  0  100  100  94  0  0  100  100  100  94  -  -  - 
  Nontyphoidal Salmonella (n=57) 63  51  43  100  92  54  23  32  84  84  100  56  -  -  - 
  S. ser. Typhimurium (n=10) 100  25  63  100  75  20  10  10  20  20  100  20  -  -  - 
  S. ser. Enteritidis (n=17) 6  6  6  100  100  12  12  6  100  100  100  18  -  -  - 
  Campylobacter (n=80)  94  73  83  95  75  -  -  -  -  -  -  -  71  49  93 
a. Surveillance data for Kisumu (urban) is limited to October 200l-October 2003. Asembo Bay (rural) is limited to 
May 1991-June 2003 and is a subset of a previously published data consisting of only patients 0-5 years old (6). 
b. CH = chloramphenicol; TS = trimethoprim-sulfamethoxazole; T=tetracycline; CP = ciprofloxacin; NA = nalidixic 
acid; A = ampicillin; SZ = sulfisoxazole; S = streptomycin; K= kanamycin; G = gentamicin; CT = ceftriaxone; A-C 
= amoxicillin-clavulanic acid, CL = clindamycin; E = erythromycin; CE =cephalothin. 
DISCUSSION
In these urban and rural communities in western 
Kenya, we found several similarities in the 
characteristics of diarrhoeal diseases in children 
<5 years old. Campylobacter was the predominant 
bacterial pathogen isolated from the stools of children 
with diarrhoea overall, with a peak around the first 
year of life in both communities. This finding is 
consistent with previous studies of Campylobacter 
in Africa and Asia (11-13). However, isolation of 
Campylobacter spp. from children without diarrhoea 
is also common in developing countries (14). In 
some studies, no statistically significant difference 
was noted in Campylobacter isolation rates in certain 
age groups (15).
 Simango and Nyahanan (16) examined rates 
of Campylobacter infection specifically among urban 
patients with diarrhoea and reported that urban 
patients tended to be older; however the conclusion 
was based on only 27 Campylobacter-positive patients 
ages 0 to 5 years. In another study comparing 
bacterial aetiologies of diarrhoea in urban vs. rural 
settings by Obi et al (2), Campylobacter was reported 
to be more common in patients with diarrhoea who 
presented to an urban clinic; however, patients were 
1 to 45 years old and age-specific isolation rates were 
not compared or reported. In contrast, we found that 
urban patients tended to be younger and presented 
for care sooner after illness onset. This difference may 
reflect better access to healthcare in the urban setting 
(17,18). Although dysentery was more common 
among rural patients, there were no significant 
differences in the isolation of specific bacterial 
pathogen associated with dysentery (Shigella). 
One explanation could be that a parasitic cause of 
dysentery, such as Entamoeba histolytica, was more 
common in the rural setting (19, 20). However, testing 
for parasitic agents was not routinely conducted for 
specimens in this study. 
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 Chickens are a common source of Campylobacter 
and children may develop protective antibodies 
against infection in a number of different ways 
other than through enteric infection. Campylobacter 
was isolated from 77% of retail poultry meat sold in 
Nairobi, Kenya (21). Oberhelman et al. (22) found 
that isolation of the same Campylobacter strain from 
a household healthy chicken and a healthy human 
within one month was highly protective against 
diarrhoea. Coke et al. (23) hypothesized that maternal 
antibodies transferred transplacentally and through 
breast milk may provide partial protection from 
Campylobacter infection in infants less than one year 
of age. This protection wanes as a function of half-life 
of maternal antibodies. 
 The identification of Salmonella Typhimurium 
and Salmonella Enteritidis as the most common 
nontyphoidal Salmonella has been noted in previous 
studies of children with bacteremia or diarrhoea (24, 
25) conducted in referral hospitals in Nairobi and Kilifi, 
Kenya. However, in both of these studies Salmonella 
Enteritidis was the most common serotype. In the 
present study, Salmonella Typhimurium was isolated 
significantly more often than Salmonella Enteritidis 
in the urban community; in contrast, Salmonella 
Typhimurium predominated among nontyphoidal 
Salmonella in the rural community. In contrast to 
the bacteremia study in Kilifi, the predominance of 
Salmonella Typhimurium over Salmonella Enteritidis 
in our study of gastroenteritis may reflect a difference 
in serotype specific invasiveness, or perhaps 
environmental, cultural, or even genetic differences 
in these two populations. The finding of Salmonella 
Heidelberg as a common cause of nontyphoidal 
paediatric salmonellosis has, to our knowledge, not 
previously been reported in Africa. 
 Where differences between urban and rural 
communities were most evident was in how patients 
and their health care providers responded to the need for 
treatment. Rural patients were more likely to have taken 
antimicrobials or herbal remedies before presenting to 
a clinic. Antimicrobials are readily accessible to patients 
without a prescription in Kenya, and parents of children 
in rural communities may treat their children more 
often than parents in urban areas due to differences in 
access to care (for instance, access to care is less readily 
available to rural patients therefore parent self-treat us 
an alternative). Although greater self-treatment might 
be hypothesized to result in differences in bacterial 
pathogens’ antibiotic susceptibility, we found antibiotic 
sensitivity profiles between urban and rural bacterial 
isolates were similar. 
 Significant differences were found in treatment 
practices among providers at the urban and rural 
clinics. The less frequent prescription of antimicrobials, 
the more frequent choice of antimicrobials with 
activity against GNR, and the more frequent use of 
hydration (ORS and IVF) suggest the providers at 
the urban clinic were more knowledgeable of and/or 
more compliant with WHO recommendations for the 
treatment of diarrhoea (10). 
 According to published reports, between 5-
38% of children with malaria may present with 
diarrhoea as a symptom (26,27); therefore, diarrhoea 
should not be considered a localizing symptom. 
WHO recommends empiric treatment for malaria 
in the case of children with non-localizing fever (10). 
Although subsequent studies have questioned the 
association between malaria and diarrhoea (28,29), 
use of sulfadoxine-pyrimethamine (SP, which was 
the first-line antimalarial treatment at the time of the 
study) was still significantly more common among 
urban patients, suggesting urban providers were 
more compliant with WHO recommendations (10) 
than their rural peers. 
 The greater empiric use of erythromycin, an 
appropriate choice in the treatment of Campylobacter 
enteritis if susceptible, in the urban clinic suggests 
these providers were making a more informed choice, 
possibly due to an awareness of the high incidence of 
Campylobacter infection in infants and young children. 
In the rural clinics, the high rates of metronidazole 
prescription for diarrhoea suggest less informed 
empiric treatment decision making; metronidazole 
is effective for amoebiasis and giardiasis but these 
infections rarely cause diarrhoea in children in this 
region (CDC unpublished data) (28). 
 Our analysis is limited to illnesses among 
children receiving care at clinics where we conducted 
surveillance; we, therefore, cannot provide population-
based incidence data. However, since our sampling 
methods were systematic we believe our isolation 
rates are representative of the disease incidence in the 
area where the study was conducted. Our study was 
also limited by inclusion of surveillance data from 
non-overlapping time periods, which could introduce 
period effects. However, separate analysis limited 
to overlapping time periods revealed no difference 
in trends; only a loss of power due to low sample 
size in the rural communities. Moreover, previous 
analysis of rural data, of which of our study used a 
subset, showed no major time-related changes that 
would alter the causes of diarrhoeal illness, likelihood 
of presentation, or health care provider treatment 
practices between non-overlapping periods (6).
 In summary, although most characteristics 
of diarrhoeal disease and its bacterial aetiology 
were similar in paediatric patients presenting to 
urban and rural clinics, we documented important 
differences in health-seeking behaviour and provider 
treatment practices. Rural patients were more likely 
to self-treat with antibiotics or herbal remedies 
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before seeking medical attention. Treatment by 
urban providers was more consistent with WHO 
recommendations. However, due to the decreased 
antimicrobial susceptibilities of the most frequently 
isolated diarrhoeal bacterial pathogens among both 
urban and rural children, the efficacy of the empiric 
antibiotic therapy provided was likely limited. 
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